Stryker (SYK) and Its Competitors Critical Analysis

Stryker (NYSE:SYK – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Stryker to related companies based on the strength of its profitability, earnings, dividends, institutional ownership, analyst recommendations, valuation and risk.

Dividends

Stryker pays an annual dividend of $3.52 per share and has a dividend yield of 1.1%. Stryker pays out 37.5% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 40.5% of their earnings in the form of a dividend. Stryker has raised its dividend for 32 consecutive years.

Profitability

This table compares Stryker and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Stryker 13.78% 23.74% 11.64%
Stryker Competitors -300.70% -179.63% -22.71%

Risk and Volatility

Stryker has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Stryker’s peers have a beta of 2.58, suggesting that their average stock price is 158% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Stryker and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stryker 0 7 21 0 2.75
Stryker Competitors 4311 10599 18393 838 2.46

Stryker presently has a consensus target price of $342.19, indicating a potential upside of 10.28%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.76%. Given Stryker’s peers higher possible upside, analysts clearly believe Stryker has less favorable growth aspects than its peers.

Valuation & Earnings

This table compares Stryker and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Stryker $25.12 billion $3.25 billion 33.05
Stryker Competitors $1.88 billion $137.20 million 5.73

Stryker has higher revenue and earnings than its peers. Stryker is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

77.1% of Stryker shares are held by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 4.6% of Stryker shares are held by company insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Stryker beats its peers on 10 of the 15 factors compared.

About Stryker

(Get Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.